Capitol Federal Financial, Inc. (CFFN)

Achilles Therapeutics Revenue

Capitol Federal Financial had revenue of $51.20M in the quarter ending June 30, 2025, with 17.53% growth. This brings the company's revenue in the last twelve months to $192.48M, down -604.77% year-over-year. In the fiscal year ending September 30, 2024, Capitol Federal Financial had annual revenue of $166.05M, down -763.63%.

• Revenue (ttm): $192.48M
• Revenue Growth: -604.77%
• P/S Ratio: 4.17
• Revenue / Employee: $292,083
• Employees: 659
• Market Cap: 802.07M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	166.05M	191.07M	-763.63%
Sep 30, 2023	-25.02M	-245.08M	-111.37%
Sep 30, 2022	220.05M	9.40M	4.46%
Sep 30, 2021	210.66M	24.02M	12.87%
Sep 30, 2020	186.63M	-40.96M	-18.00%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.